Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys

Psychopharmacology

Volumn 176, Issue 2, 2004, Pages 204-213

  Stevens Negus, S ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

Choice; Cocaine; Kappa opioid receptors; Norbinaltorphimine; U50,488

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; COCAINE; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; NORBINALTORPHIMINE;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DECISION MAKING; DOSE RESPONSE; DRUG EFFECT; FOOD; MALE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; BEHAVIOR, ADDICTIVE; CHOICE BEHAVIOR; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; MACACA MULATTA; MALE; NALTREXONE; RECEPTORS, OPIOID, KAPPA;

EID: 8744255273     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-1878-7     Document Type: Article

References (54)

1. Acri JB, Thompson AC, Shippenberg T (2001) Modulation of pre-and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593. Synapse 39:343-350
2. Bergman J, Warren PH (1989) Effects of kappa opioids on schedule-controlled behavior of squirrel monkeys. J Pharmacol Exp Ther 248:1102-1108
3. Bowen CA, Stevens Negus S, Zong R, Neumeyer JL, Bidlack JM, Mello NK (2003) Effects of mixed-action kappa/mu opioids on cocaine self-administration and cocaine discrimination by rhesus monkeys. Neuropsychopharmacology 28:1125-1139
4. Butelman ER, Negus SS, Ai Y, de Costa BR, Woods JH (1993) Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys. J Pharmacol Exp Ther 267:1269-1276
5. Cepeda MS, Farrar JT, Baumgarten M, Boston R, Carr DB, Strom BL (2003) Side effects of opioids during short-term administration: effect of age, gender, and race. Clin Pharmacol Ther 74:102-112
6. Cosgrove KP, Carroll ME (2002) Effects of bremazocine on self-administration of smoked cocaine base and orally delivered ethanol, phencyclidine, saccharin, and food in rhesus monkeys: a behavioral economic analysis. J Pharmacol Exp Ther 301:993-1002
7. Covington HE III, Miczek KA (2001) Repeated social-defeat stress, cocaine or morphine. Effects on behavioral sensitization and intravenous cocaine self-administration "binges". Psychopharmacology 158:388-398
8. Crawford CA, McDougall SA, Bolanos CA, Hall S, Berger SP (1995) The effects of the kappa agonist U-50,488 on cocaine-induced conditioned and unconditioned behaviors and Fos immunoreactivity. Psychopharmacology 120:392-399
9. Devine DP, Leone P, Pocock D, Wise RA (1993) Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J Pharmacol Exp Ther 266:1236-1246
10. Donzanti BA, Althaus JS, Payson MM, Von Voigtlander PF (1992) Kappa agonist-induced reduction in dopamine release: site of action and tolerance. Res Commun Chem Pathol Pharmacol 78:193-210
11. Dykstra LA, Gmerek DE, Winger G, Woods JH (1987) Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects. J Pharmacol Exp Ther 242:413-420
12. Glick SD, Maisonneuve EM, Raucci J, Archer S (1995) Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Res 681:147-152
13. Goeders NE (2002) The HPA axis and cocaine reinforcement. Psychoneuroendocrinology 27:13-33
14. Griffiths RR, Wurster RM, Brady JV (1975) Discrete-trial choice procedure: effects of naloxone and methadone on choice between food and heroin. Pharmacol Rev 27:357-365
15. Haile CN, GrandPre T, Kosten TA (2001) Chronic unpredictable stress, but not chronic predictable stress, enhances the sensitivity to the behavioral effects of cocaine in rats. Psychopharmacology 154:213-220
16. Haney M, Collins ED, Ward AS, Foltin RW, Fischman MW (1999) Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans. Psychopharmacology 143:102-110
17. Hansen J, Ginman C, Hartvig P, Jakobsson PA, Nilsson MI, Rane A, Sawe J, Anggard E (1982) Clinical evaluation of oral methadone in treatment of cancer pain. Acta Anaesthesiol Scand Suppl 74:124-127
18. Iwamoto ET (1985) Place-conditioning properties of mu, kappa, and sigma opioid agonists. Alcohol Drug Res 6:327-339
19. Izenwasser S, Acri JB, Kunko PM, Shippenberg T (1998) Repeated treatment with the selective kappa opioid agonist U-69593 produces a marked depletion of dopamine D2 receptors. Synapse 30:275-283
20. Johanson CE (1975) Pharmacological and environmental variables affecting drug preference in rhesus monkeys. Pharmacol Rev 27:343-355
21. Kantak KM, Riberdy A, Spealman RD (1999) Cocaine-opioid interactions in groups of rats trained to discriminate different doses of cocaine. Psychopharmacology 147:257-265
22. Kelleher RT, Goldberg SR (1976) Introduction: complex schedules of drug injection. Pharmacol Rev 27:341-342
23. Maisonneuve IM, Archer S, Glick SD (1994) U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats. Neurosci Lett 181:57-60
24. Marinelli M, Barrot M, Simon H, Oberlander C, Dekeyne A, Le Moal M, Piazza PV (1998) Pharmacological stimuli decreasing nucleus accumbens dopamine can act as positive reinforcers but have a low addictive potential. Eur J Neurosci 10:3269-3275
25. McLaughlin JP, Marton-Popovici M, Chavkin C (2003) Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci 23:5674-5683
26. Mello NK, Negus SS (1996) Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14:375-424
27. Mello NK, Negus SS (1998) Effects of kappa opioid agonists on cocaine- and food-maintained responding by rhesus monkeys. J Pharmacol Exp Ther 286:812-824
28. Morgan D, Grant KA, Gage HD, Mach RH, Kaplan JR, Prioleau O, Nader SH, Buchheimer N, Ehrenkaufer RL, Nader MA (2002) Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nat Neurosci 5:169-174
29. Mori T, Nomura M, Nagase H, Narita M, Suzuki T (2002) Effects of a newly synthesized kappa-opioid receptor agonist, TRK-820, on the discriminative stimulus and rewarding effects of cocaine in rats. Psychopharmacology 161:17-22
30. Nabeshima T, Katoh A, Wada M, Kameyama T (1992) Stress-induced changes in brain Met-enkephalin, Leu-enkephalin and dynorphin concentrations. Life Sci 51:211-217
31. Negus SS (2003) Rapid assessment of choice between cocaine and food in rhesus monkeys: effects of environmental manipulations and treatment with D-amphetamine and flupenthixol. Neuropsychopharmacology 28:919-931
32. Negus SS, Mello NK (2004) Effects of chronic methadone treatment on cocaine- and food-maintained responding under second-order, progressive-ratio and concurrent-choice schedules in rhesus monkeys. Drug Alcohol Depend (in press)
33. Negus SS, Burke TF, Medzihradsky F, Woods JH (1993) Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine. J Pharmacol Exp Ther 267:896-903
34. Negus SS, Mello NK, Portoghese PS, Lin CE (1997) Effects of kappa opioids on cocaine self-administration by rhesus monkeys. J Pharmacol Exp Ther 282:44-55
35. Negus SS, Gatch MB, Mello NK, Zhang X, Rice K (1998) Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys. J Pharmacol Exp Ther 286:362-375
36. Pfeiffer A, Brantl V, Herz A, Emrich HM (1986) Psychotomimesis mediated by kappa opiate receptors. Science 233:774-776
37. Pliakas AM, Carlson RR, Neve RL, Konradi C, Nestler EJ, Carlezon WA Jr (2001) Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J Neurosci 21:7397-7403
38. Portoghese PS, Lipkowski AW, Takemori AE (1987) Binaltorphimine and norbinaltorphimine, potent and selective kappa opioid receptor antagonists. Life Sci 40:1287-1292
39. Przewlocki R, Lason W, Hollt V, Silberring J, Herz A (1987) The influence of chronic stress on multiple opioid peptide systems in the rat: pronounced effects upon dynorphin in spinal cord. Brain Res 413:213-219
40. Schenk S, Partridge B, Shippenberg TS (1999) U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking. Psychopharmacology 144:339-346
41. Shippenberg TS, Herz A (1986) Differential effects of mu and kappa opioid systems on motivational processes. NIDA Res Monogr 75:563-566
42. Shippenberg TS, Rea W (1997) Sensitization to the behavioral effects of cocaine: modulation by dynorphin and kappa-opioid receptor agonists. Pharmacol Biochem Behav 57:449-455
43. Spanagel R, Herz A, Shippenberg TS (1990) The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J Neurochem 55:1734-1740
44. Spealman RD, Bergman J (1992) Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids. J Pharmacol Exp Ther 261:607-615
45. Spealman RD, Bergman J (1994) Opioid modulation of the discriminative stimulus effects of cocaine: comparison of micro, kappa and delta agonists in squirrel monkeys discriminating low doses of cocaine. Behav Pharmacol 5:21-31
46. Suh HW, Song DK, Huh SO, Kim YH (2000) Involvement of dynorphin in immobilization stress-induced antinociception in the mouse. Eur Neuropsychopharmacol 10:407-413
47. Suzuki T, Shiozaki Y, Masukawa Y, Misawa M, Nagase H (1992) The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference. Jpn J Pharmacol 58:435-442
48. Tang AH, Collins RJ (1985) Behavioral effects of a novel kappa opioid analgesic, U-50488, in rats and rhesus monkeys. Psychopharmacology 85:309-314
49. Thompson AC, Zapata A, Justice JB Jr, Vaughan RA, Sharpe LG, Shippenberg TS (2000) Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine. J Neurosci 20:9333-9340
50. Verbalis JG, Richardson DW, Stricker EM (1987) Vasopressin release in response to nausea-producing agents and cholecystokinin in monkeys. Am J Physiol 252:R749-R753
51. Walsh SL, Geter-Douglas B, Strain EC, Bigelow GE (2001) Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans. J Pharmacol Exp Ther 299:147-158
52. Woods JH, Gmerek DE (1985) Substitution and primary dependence studies in animals. Drug Alcohol Depend 14:233-247
53. Woolverton WL, Balster RL (1979) The effects of lithium on choice between cocaine and food in the rhesus monkey. Commun Psychopharmacol 3:309-318
54. Zaratin P, Clarke GD (1994) Comparative effects of selective kappa-opioid receptor agonists on dopamine levels in the dorsal caudate of freely moving rats. Eur J Pharmacol 264:151-156